
Placebo

Galantamine

Adjusted mean difference

95% CI


APOE ϵ4 noncarriers

0.48

0.41

0.07

−0.10; 0.25

APOE ϵ4 carriers

0.77

0.49

0.28

0.07; 0.50

 Data presented as percentage change per year. The numbers of subjects per cell were as follows: APOE ϵ4 noncarriers, total n = 109 (placebo, n = 54; galantamine, n = 55), APOE ϵ4 carriers, total n = 97 (placebo, n = 54; galantamine, n = 43). APOE, apolipoprotein E; CI, confidence interval.